Skip to main content

MoneyWorks4Me

Earum Pharmaceuticals informs about disclosure

25 Aug 2022 Evaluate

Earum Pharmaceuticals has informed that the exchange has received the disclosure under Regulation 29(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for Payal B Patel.

The above information is a part of company’s filings submitted to BSE.

Peers
Company Name CMP
Redington 340.75
Adani Enterprises 2660.00
Amrapali Industries 32.15
Maxgrow India 171.35
Rashi Peripheral 645.85
View more..